Treatment of HIV-associated nephropathies

Usama Elewa, Ana Maria Sandri, Stacey A. Rizza, Fernando C. Fervenza

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


In patients with HIV, the use of highly active antiretroviral therapy has improved life expectancy. At the same time, this increase in life expectancy has been associated with a higher frequency of chronic kidney disease due to factors other than HIV infection. Besides HIV-associated nephropathy, a number of different types of immune complex and non-immune complex-mediated processes have been identified on kidney biopsies, including vascular disease (nephrosclerosis), diabetes, and drug-related renal injury. In this setting, renal biopsy needs to be considered in order to obtain the correct diagnosis in individual patients with HIV and kidney impairment. Many issues regarding the optimal treatment of the different pathological processes affecting the kidneys of these patients have remained unresolved. Further research is needed in order to optimize treatment and renal outcomes in patients with HIV and kidney disease.

Original languageEnglish (US)
Pages (from-to)c346-c354
JournalNephron - Clinical Practice
Issue number4
StatePublished - Jul 2011


  • Human immunodeficiency virus
  • Nephropathy
  • Therapy

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Treatment of HIV-associated nephropathies'. Together they form a unique fingerprint.

Cite this